Subclinical antibody-mediated rejection due to anti-human-leukocyte-antigen-DR53 antibody accompanied by plasma cell-rich acute rejection in a patient with cadaveric kidney transplantation

Rates and Determinants of Progression to Graft Failure in Kidney Allograft Recipients WithDe NovoDonor-Specific Antibody

(2015) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts

(2015) A. Loupy et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

A suspected case of plasma cell-rich acute renal transplant rejection associated with de novo donor-specific antibody

(2015) Mikiko Yoshikawa et al.   NEPHROLOGY

A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient

(2015) Toshinari Fujimoto et al.   NEPHROLOGY

Persistent BK Viremia Does Not Increase Intermediate-Term Graft Loss but Is Associated with De Novo Donor-Specific Antibodies

(2014) D. Sawinski et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation

(2014) Maiko Furuya et al.   NEPHROLOGY

Using individual DSA titers to assess for accommodation after late humoral rejection

(2014) Guido Filler et al.   PEDIATRIC TRANSPLANTATION

Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant

(2012) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Subclinical Rejection in Stable Positive Crossmatch Kidney Transplant Patients: Incidence and Correlations

(2009) E. S. Kraus et al.   AMERICAN JOURNAL OF TRANSPLANTATION